Current Suspected Overdose Deaths in Delaware for 2024: Get Help Now!

Find school water testing results and additional resources

Attention Medicaid Participants: Eligibility Renewals Restarted April 1, 2023

Delaware.gov logo

DHSS Menu


Delaware Health Alert Network #170

February 6, 2009 8:42 am


Health Alert
IMPORTANT FDA PRODUCT NOTIFICATION
POSTED FEBRUARY 5, 2009


PRODUCT:

FLUVIRIN ® (Influenza Virus Vaccine) Luer-Lok pre-filled syringes

MANUFACTURER:

Novartis Vaccines and Diagnostics Limited
Liverpool United Kingdom

DATE NOTIFICATION INITIATED:

February 4, 2009

NUMBER / EXPIRATION DATE:


Lot Number Expiration Date
878771P 05 / 2009
878772P 05 / 2009
878773P 05 / 2009
878775P 05 / 2009
878776P 05 / 2009


REASON:

Novartis Vaccines and Diagnostics Inc. has requested their customers to immediately discontinue use of and return any remaining doses they may have from five lots of FLUVIRIN® Influenza vaccine Luer-Lok pre-filled syringes.

Routine stability testing of FLUVIRIN in prefilled Luer-Lok syringes revealed a minor deviation in the potency of the A/Brisbane (H1N1) component of the vaccine. The vaccine met all required specifications at the time of release and has been monitored in monthly time intervals during its shelf life; it has consistently met specification until the most recent test point in early January 2009 that identified a minimal decrease in H1N1 antigen content.

The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and Novartis Vaccines have agreed that no public health impact is expected because:

  1. all of the affected vaccine was shipped when the vaccine met potency requirements,
  2. most influenza vaccine in the US is administered during October and November, months when the vaccine met potency requirements, and
  3. the decrease in antigen content is small and would have a negligible if any effect on immune response to vaccination.

Revaccination of patients that have been vaccinated with the affected lots is not necessary.

For additional information, please visit the FDA website at http://www.fda.gov/cber/recalls/novflu020409.htm or call the immunization program hotline 1-800-282-8672.

Categories of Health Alert messages:

  • Health Alert: Conveys the highest level of importance; warrants immediate action or attention.
  • Health Advisory: Provides important information for a specific incident or situation; may not require immediate action.
  • Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
NOTE: This page is for informational purposes only and dated material (e.g. temporary websites) may not be available.





About the Department
Secretary's Letter
Secretary Bio
Newsroom
State Jobs
Calendar
Delaware Health Care Commission
DHSS Administration Contact
Federal COVID Funding Dashboard

Publications & Reports
Aging and Physical Disabilities
Child Support Services
Social Services
Health Care Quality
Office of the Secretary - Administration
Medicaid & Medical Assistance
Public Health

Developmental Disabilities Services
Substance Abuse & Mental Health
Visually Impaired
Councils and Committees
Trauma Informed
CostAware
Volunteer Delaware
FOIA Request Form



+